Scarica l'app Stockscreener
50.89
5.69%
-3.07
Pre-mercato:
50.05
-0.84
-1.65%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Hims & Hers Health, Inc. $HIMS Stock Position Raised by Fiduciary Alliance LLC - MarketBeat
Range Financial Group LLC Invests $996,000 in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat
U.S. FDA sends drug advertising warning letters to Lilly, Novo, Hims - Red Lake Nation News
FDA takes aim at Hims & Hers and other sellers of unofficial weight loss drugs - Anchorage Daily News
FDA targets Hims & Hers, posts more than 100 letters to drugmakers - WTVC
Lilly, Novo, Hims Get FDA Warnings About Misleading Drug Communications - PharmTech
FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitz - NonStop Local Billings
Why The FDA — And Investors — Just Slammed Hims Stock - Investor's Business Daily
FDA warns Hims & Hers and other weight loss drugmakers to remove 'false and misleading' advertising - Fortune
Hims falls after FDA posts warning letter - Sherwood News
FDA’s pharma ad crackdown targets Hims & Hers, weight loss drugs - Dallas News
Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why - Yahoo Finance
Hims & Hers shares drop 6% after FDA warning on semaglutide marketing claims - CryptoRank
Gold's record high, Rocket Lab equity offering, FDA warns Hims - Yahoo Finance
FDA takes aim at Hims and other telehealth services in drug advertising blitz - Daily Breeze
Promising Medical Stocks To Add to Your WatchlistSeptember 16th - MarketBeat
BigBear.ai, Tesla, Hims & Hers, Rocket Lab, Warner Bros Discovery: Stocks Making The Biggest Moves Today - stocktwits.com
What's Going On With Hims & Hers Health Stock On Tuesday?Hims & Hers Health (NYSE:HIMS) - Benzinga
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Yahoo Finance
Market Dips As Fed Meets And Companies Make Headlines - Finimize
US FDA warns Hims & Hers over misleading claims on diabetes, weight-loss drugs - Reuters
Huge News for Hims & Hers Stock - The Motley Fool
Huge News for Hims & Hers Stock - The Globe and Mail
Hims & Hers falls 8% as FDA issues warning letter over compounded weight loss drug - Seeking Alpha
Hims & Hers stock falls after FDA warning over semaglutide claims By Investing.com - Investing.com South Africa
Hims & Hers stock falls after FDA warning over semaglutide claims - Investing.com
Hims & Hers Expands AI and Technology Focus to Advance Digital Care - TradingView
Hims & Hers Stock Draws Investor Attention After Tumbling 7% – Here’s What Happened - stocktwits.com
Hims & Hers Health (HIMS): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Aug Weekly: Is Hims Hers Health Inc gaining market shareJuly 2025 Breakouts & Risk Controlled Stock Pick Alerts - خودرو بانک
Hims & Hers falls after FDA commissioner says its Super Bowl ad breached regulations - Sherwood News
Aug Macro: Is Hims Hers Health Inc stock risky to hold now2025 Price Action Summary & Real-Time Volume Analysis - خودرو بانک
Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Best Healthcare Stocks To Watch NowSeptember 15th - MarketBeat
Promising Healthcare Stocks To Keep An Eye OnSeptember 14th - MarketBeat
Hims & Hers Stock: How It Found Itself in the FDA’s Crosshairs - Barron's
Hims & Hers Stock Falls After FDA Warns on Super Bowl Campaign - ca.finance.yahoo.com
OMCL or HIMS: Which Is the Better Value Stock Right Now? - Yahoo Finance
Hims and Hers stock faces pressure as BofA reiterates Underperform rating - Investing.com
Musk buys Tesla, China vs. US chips, Hims: Trending Tickers - Yahoo Finance
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know - Yahoo Finance
0.76%
1.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):